UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
MEDICAL TECHNOLOGY & INNOVATIONS, INC.
------------------------------------------------------
(Name of small business issuer in its charter)
FLORIDA 65-2954561
- ----------------------------- -------------------------
(State or other jurisdiction (I.R.S. Employer or
of incorporation organization) Identification No.)
3725 Investment Lane, Riviera Beach, FL 33404
----------------------------------------- ----------------------
(Address of principal place of business) (zip code)
Medical Technology & Innovations, Inc.
Year 2000 Supplemental Employee/Consultant Stock Compensation Plan
------------------------------------------------------
(Full title of the plan)
Mintmire & Associates
265 Sunrise Avenue, Suite 204,
Palm Beach, FL 33480
Tel: (561) 832-5696
-----------------------------------------------------------
(Name, address and telephone number of agent for service)
CALCULATION OF REGISTRATION FEE
PROPOSED PROPOSED
TITLE OF AMOUNT MAXIMUM MAXIMUM
SECURITIES OF SHARES OFFERING AGGREGATE AMOUNT OF
TO BE TO BE PRICE OFFERING REGISTRATION
REGISTERED REGISTERED PER SHARE PRICE FEE (1)
------------ ------------- ---------- ---------- ------------
Common Stock 2,000,000 (2) $0.11 $220,000 $58.08
No par
<PAGE>
(1) Estimated pursuant to Rule 457(c) and 457(h) solely for the purpose of
calculating the Registration Fee, which is based on the closing sale price of
the Company's Common Stock on the average of November 20, 21, 22, 24, 28, 2000
as reported on the OTC Electronic Bulletin Board.
(2) Represents the maximum number of shares which may be granted under the
Medical Technology & Innovations, Inc. Year 2000 Supplemental
Employee/Consultant Stock Compensation Plan (the "Plan").
PART II
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference
The following documents which have been heretofore filed with the
Securities and Exchange Commission (the "Commission") by the Registrant pursuant
to the Securities Exchange Act of 1934 (the "Exchange Act") are incorporated by
reference in this Registration Statement:
(1) The Registrant's Annual Report on Form l0-KSB for the fiscal
year ended June 30, 2000;
(2) All other reports filed by the Registrant with the Commission
pursuant to Section 13(a) or Section 15(d) of the Exchange Act since the end of
the fiscal year covered by the Registrant's Annual Report referred to above; and
(3) The description of the Common Stock of the Registrant contained
in the Registrant's Registration Statement.
All documents filed by the Registrant with the Commission pursuant to
Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of
this Registration Statement and prior to the filing of a post-effective
amendment hereto which indicates that all securities offered have been sold or
which deregisters all securities then remaining unsold, shall be deemed to be
incorporated by reference herein and to be a part hereof from the date of filing
of such documents.
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
Not applicable.
Item 6. Indemnification of Directors and Officers.
The Bylaws of the Registrant contain provisions which provide for the
indemnification of directors, officers, and other employees or agents of the
Registrant properly appointed to serve
<PAGE>
in an official capacity who while acting in good faith, in the best interests of
the Registrant, and within the scope of their offices, are or are threatened to
be named as a defendant or respondent in a civil or criminal action. The extent
of the indemnification is limited to judgements, penalties, fines, settlements
and reasonable expenses actually incurred.
Item 7. Exemption from Registration Claimed.
Not applicable.
Item 8. Exhibits.
* 5.2 Opinion of Mintmire & Associates
* 10.2 Medical Technology & Innovations, Inc. Year 2000 Supplemental
Employee/Consultant Stock Compensation Plan
* 23.2 Consent of Simon Lever & Company
23.3 Consent of Mintmire & Associates (contained in the opinion
filed as Exhibit 5.2 hereof)
----------------------------
(* filed herewith)
Item 9. Undertakings.
The Registrant hereby undertakes:
(a) (1) to file, during any period in which it offers or sells securities, a
post effective amendment to this registration statement to include any
prospectus required by Section 10(a) (3) of the Securities Act;
(2) that, for the purpose of determining any liability under the
Securities Act of 1933, to treat each post-effective amendment as a new
registration statement of the securities offered, and the offering of the
securities at that time to be the initial bona fide offering;
(3) to remove from registration by means of a post-effective amendment
any of the securities that remain unsold at the end of the offering.
Insofar as indemnification for liabilities arising under the Securities
Act of 1933 (the "Act") may be permitted to directors, officers, and controlling
persons of the small business issuer pursuant to the foregoing provisions, or
otherwise, the small business issuer has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy
as expressed in the Act and is, therefore, unenforceable. In the event that a
claim for indemnification against such liabilities (other than the payment by
the Company in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in connection with the
securities being registered, the Company will, unless in the opinion of this
counsel that matter has been settled by controlling precedent, submit to a court
of appropriate jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Act and will be governed by the final
jurisdiction of such issue.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf, in the City of Riviera Beach, Florida, on
November 27, 2000.
MEDICAL TECHNOLOGY & INNOVATIONS, INC.
By: /s/ Jeremy Feakins
---------------------------
Jeremy Feakins
CEO
Pursuant to the requirements of the Securities Act of 1933, this registration
statement has been signed by the following persons in the capacities and on the
dates indicated.
Signature Title Date
------------------------- ------------------- -------------------
/s/ Jeremy Feakins
------------------------- CEO, Director November 27, 2000
Jeremy Feakins
/s/ Joseph DelVecchio
------------------------- Executive Vice Pres. November 28, 2000
Joseph DelVecchio COO, Director
/s/ Albert Dugan
------------------------- Secretary November 28, 2000
Albert Dugan
/s/ Dennis Surovcik
------------------------- November 27, 2000
Dennis Surovcik Director
